help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2008-0253
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mallat, Z.
Right arrow Articles by Boekholdt, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mallat, Z.
Right arrow Articles by Boekholdt, S. M.
Related Collections
Right arrow Cardiovascular Endocrinology
Right arrow Diabetes and Insulin
Right arrow Metabolism
The Journal of Clinical Endocrinology & Metabolism Vol. 94, No. 1 255-260
Copyright © 2009 by The Endocrine Society

Retinol-Binding Protein 4 and Prediction of Incident Coronary Events in Healthy Men and Women

Ziad Mallat, Tabassome Simon, Joelle Benessiano, Karine Clément, Soraya Taleb, Nicholas J. Wareham, Robert Luben, Kay-Tee Khaw, Alain Tedgui and S. Matthijs Boekholdt

Institut National de la Santé et de la Recherche Médicale (INSERM) (Z.M., T.S., J.B., S.T., A.T.), Université Paris Descartes and Assistance Publique-Hopitaux de Paris, Paris Cardiovascular Research Center (PARCC), 75015 Paris, France; Department of Pharmacology (T.S.), Assistance Publique-Hopitaux de Paris (AP-HP), Hôpital Saint-Antoine-Unité de Recherche Clinique de l’EST Parisien, and Université Pierre et Marie Curie, 75012 Paris, France; Centre d’Investigation Clinique et Centre de Ressources Biologiques (J.B.), AP-HP, Hôpital Bichat, 75018 Paris, France; INSERM (K.C.), Unité Mixte de Recherche en Santé Unit 872, University Pierre et Marie Curie, 75012 Paris, France; Medical Research Council (N.J.W.), Epidemiology Unit, CB1 9NL Cambridge, United Kingdom; Department of Public Health and Primary Care (R.L., K.-T.K.), University of Cambridge, CB3 0DS Cambridge, United Kingdom; and Departments of Cardiology and Vascular Medicine (S.M.B.), Academic Medical Center, 1100 D Amsterdam, The Netherlands

Address all correspondence and requests for reprints to: Ziad Mallat, M.D., Ph.D., Institut National de la Santé et de la Recherche Médicale Unit 689, Hôpital Lariboisière, 75010 Paris, France. E-mail: ziad.mallat{at}larib.inserm.fr.

Context: Recent studies reported that retinol-binding protein 4 (RBP4) has a causal role in insulin resistance and suggested that its circulating levels may predict cardiovascular disease. However, the latter assumption has not yet been tested.

Objective: We assessed the value of RBP4 measurement in the prediction of incident coronary artery disease (CAD).

Design: We conducted a nested case-control study of incident CAD (n = 1036 cases vs. n = 1889 controls) selected from among 25,336 participants of the EPIC-Norfolk study.

Setting: Healthy men and women, aged between 45 and 79 yr, were recruited from age-sex registers of general practices in Norfolk.

Patients and Other Participants: Participants completed a baseline questionnaire survey between 1993 and 1997, attended a clinic visit, and were followed for an average of 6 yr. Cases (n = 1036) were participants who developed CAD during the follow-up. Controls (n = 1889) matched by age, sex, and enrollment time remained free of any CAD during follow-up.

Main Outcomes Measure: Risk of incident fatal or nonfatal CAD according to RBP4 quartiles was assessed.

Results: RBP4 levels were higher in cases than in controls. RBP4 levels correlated weakly with body mass index, waist-to-hip ratio, systolic and diastolic blood pressure, and total and low-density lipoprotein-cholesterol and were inversely associated with C-reactive protein concentrations. The strongest correlation was found with triglycerides. The risk of incident CAD was associated with increasing quartiles of RBP4 levels (P = 0.03). However, adjustment for cardiovascular risk factors abolished this association.

Conclusions: Measurement of serum RBP4 does not provide added value for predicting CAD risk beyond traditional risk factors.




This article has been cited by other articles:


Home page
Diabetes CareHome page
E. Ingelsson and L. Lind
Circulating Retinol-Binding Protein 4 and Subclinical Cardiovascular Disease in the Elderly
Diabetes Care, April 1, 2009; 32(4): 733 - 735.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2009 by The Endocrine Society